Zobrazeno 1 - 10
of 513
pro vyhledávání: '"Dunn, JA"'
Publikováno v:
Patient Preference and Adherence, Vol Volume 13, Pp 339-349 (2019)
Elizabeth Mostofsky,1–3 Jillian A Dunn,3 Sonia Hernández-Díaz,3 Anna C Johansson,2,4 Murray A Mittleman1–4 1Cardiovascular Epidemiology Research Unit, Beth Israel Deaconess Medical Center, Boston, MA, USA; 2Department of Medicine, Beth Israel D
Externí odkaz:
https://doaj.org/article/04c91210419242c69de83a021562416d
Autor:
Bartlett, John MS, Bayani, Jane, Kornaga, Elizabeth, Xu, Keying, Pond, Greg R, Piper, Tammy, Mallon, Elizabeth, Yao, Cindy Q, Boutros, Paul C, Hasenburg, Annette, Dunn, JA, Markopoulos, Christos, Dirix, Luc, Seynaeve, Caroline, van de Velde, Cornelis JH, Stein, Robert C, Rea, Daniel
Publikováno v:
NPJ breast cancer, vol 7, iss 1
Multiparametric assays for risk stratification are widely used in the management of both node negative and node positive hormone receptor positive invasive breast cancer. Recent data from multiple sources suggests that different tests may provide dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::72cc7f919d37a473f3f32d5bcce4ce08
https://escholarship.org/uc/item/82r0v68b
https://escholarship.org/uc/item/82r0v68b
Autor:
Corrie, PG, Marshall, A, Nathan, PD, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, CG, Marples, M, Danson, SJ, Marshall, E, Houston, SJ, Board, RE, Waterston, AM, Nobes, JP, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, PM, Ottensmeier, CH, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, EO, Harman, C, Weiss, M, Myers, KA, Chhabra, A, Rodwell, SH, Dunn, JA, Middleton, MR, Investigators, AVAST-M
Publikováno v:
ANNALS OF ONCOLOGY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::8b659aae2c5afd3627b833b57ae597d8
Autor:
Corrie, PG, Marshall, A, Nathan, PD, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, CG, Marples, M, Danson, SJ, Marshall, E, Houston, SJ, Board, RE, Waterston, AM, Nobes, JP, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, PM, Ottensmeier, CH, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, EO, Harman, C, Weiss, M, Myers, KA, Chhabra, A, Rodwell, SH, Dunn, JA, Middleton, MR, AVAST-M Investigators, Nathan, P, Dziewulski, P, Holikova, S, Panwar, U, Thomas, A, Corrie, P, Sirohi, B, Kelly, C, Middleton, M, Danson, S, Lester, J, Ajaz, M, Houston, S, Board, R, Eaton, D, Waterston, A, Nobes, J, Loo, S, Gray, G, Stubbings, H, Marsden, J, Patel, P, Ottensmeier, C, Dega, R, Herbert, C, Price, C, Brunt, M, Scott-Brown, M, Hamilton, J, Hayward, RL, Smyth, J, Woodings, P, Nayak, N, Burrows, L, Wolstenholme, V, Wagstaff, J, Nicolson, M, Wilson, A, Barlow, C, Scrase, C, Podd, T, Gonzalez, M, Stewart, J, Highley, M, Grumett, S, Talbot, T, Nathan, K, Coltart, R, Gee, B
Publikováno v:
Annals of Oncology
Corrie, P G, Marshall, A, Nathan, P D, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, C G, Marples, M, Danson, S J, Marshall, E, Houston, S J, Board, R E, Waterston, A M, Nobes, J P, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, P M, Ottensmeier, C H, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, E O, Harman, C, Weiss, M, Myers, K A, Chhabra, A, Rodwell, S H, Dunn, J A & Middleton, M R 2019, ' Adjuvant bevacizumab for melanoma patients at high risk of recurrence : survival analysis of the AVAST-M trial ', Annals of Oncology, vol. 30, no. 12, pp. 2013-2014 . https://doi.org/10.1093/annonc/mdz237
Corrie, P G, Marshall, A, Nathan, P D, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, C G, Marples, M, Danson, S J, Marshall, E, Houston, S J, Board, R E, Waterston, A M, Nobes, J P, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, P M, Ottensmeier, C H, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, E O, Harman, C, Weiss, M, Myers, K A, Chhabra, A, Rodwell, S H, Dunn, J A & Middleton, M R 2018, ' Adjuvant bevacizumab for melanoma patients at high risk of recurrence : survival analysis of the AVAST-M trial ', Ann Oncol., vol. 29, no. 8, pp. 1843-1852 . https://doi.org/10.1093/annonc/mdy229
Corrie, P G, Marshall, A, Nathan, P D, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, C G, Marples, M, Danson, S J, Marshall, E, Houston, S J, Board, R E, Waterston, A M, Nobes, J P, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, P M, Ottensmeier, C H, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, E O, Harman, C, Weiss, M, Myers, K A, Chhabra, A, Rodwell, S H, Dunn, J A & Middleton, M R 2019, ' Adjuvant bevacizumab for melanoma patients at high risk of recurrence : survival analysis of the AVAST-M trial ', Annals of Oncology, vol. 30, no. 12, pp. 2013-2014 . https://doi.org/10.1093/annonc/mdz237
Corrie, P G, Marshall, A, Nathan, P D, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, C G, Marples, M, Danson, S J, Marshall, E, Houston, S J, Board, R E, Waterston, A M, Nobes, J P, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, P M, Ottensmeier, C H, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, E O, Harman, C, Weiss, M, Myers, K A, Chhabra, A, Rodwell, S H, Dunn, J A & Middleton, M R 2018, ' Adjuvant bevacizumab for melanoma patients at high risk of recurrence : survival analysis of the AVAST-M trial ', Ann Oncol., vol. 29, no. 8, pp. 1843-1852 . https://doi.org/10.1093/annonc/mdy229
Background Bevacizumab is a recombinant humanised monoclonal antibody to vascular endothelial growth factor shown to improve survival in advanced solid cancers. We evaluated the role of adjuvant bevacizumab in melanoma patients at high risk of recurr
Autor:
Godin S, Leo Andrew Benedict, Danielle Tatum, Raminder Nirula, Carrick Mm, Azmi H, Gina R. Mallory, Angela Coates, Chang Dsj, Inaba K, Li T, Rao K, Sarah Lombardo, Paul T. Engels, Chad G. Ball, Ali Salim, Xiao J, Joao B Rezende-Neto, Dunn Ja, Thomas Schroeppel, Widdel L, Jonathan P. Meizoso, Kaul S, Sandro Rizoli, Bryan A. Cotton, OʼBosky Kr, Galinos Barmparas, Dhillon Nk, Leonard Sd, Tomas Jacome, de León La, Eric J. Ley
Publikováno v:
Journal of Trauma and Acute Care Surgery. 84:234-244
Beta blockers, a class of medications that inhibit endogenous catecholamines interaction with beta adrenergic receptors, are often administered to patients hospitalized after traumatic brain injury (TBI). We tested the hypothesis that beta blocker us
Autor:
Hall, PS, Smith, A, Hulme, C, Vargas-Palacios, A, Makris, A, Hughes-Davies, L, Dunn, JA, Bartlett, JMS, Cameron, DA, Marshall, A, Campbell, A, Macpherson, IR, Rea, D, Francis, A, Earl, H, Morgan, A, Stein, RC, McCabe, C
Background: \ud Precision medicine is heralded as offering more effective treatments to smaller targeted patient populations. In breast cancer, adjuvant chemotherapy is standard for patients considered as high-risk after surgery. Molecular tests may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9a799b2d56e7779f5700f1bc7871a969
https://eprints.gla.ac.uk/144331/7/144331.pdf
https://eprints.gla.ac.uk/144331/7/144331.pdf
Autor:
Neoptolemos JP (AUTHOR), Dunn JA (AUTHOR), Stocken DD (AUTHOR), Almond J (AUTHOR), Link K (AUTHOR), Beger H (AUTHOR), Bassi C (AUTHOR), Falconi M (AUTHOR), Pederzoli P (AUTHOR), Dervenis C (AUTHOR), Fernandez-Cruz L (AUTHOR), Lacaine F (AUTHOR), Pap A (AUTHOR), Spooner D (AUTHOR), Kerr DJ (AUTHOR), Friess H (AUTHOR), Büchler MW (AUTHOR), European Study Group for Pancreatic Cancer (CORPORATE AUTHOR), Neoptolemos, J P1 (AUTHOR), Dunn, J A (AUTHOR)
Publikováno v:
Lancet. 11/10/2001, Vol. 358 Issue 9293, p1576-1585. 10p.
Autor:
Midgley, RSJ, McConkey, CC, Langman, MJ, Smith, JL, Julier, P, Iveson, C, Johnstone, E, Chen, X-H, Dunn, JA, Kerr, DJ, Grp, VICTORT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5853b36ca3b09c6a45e037da73ca6124
https://ora.ox.ac.uk/objects/uuid:2dd6aab5-04aa-43fd-b1f3-e4002b70f620
https://ora.ox.ac.uk/objects/uuid:2dd6aab5-04aa-43fd-b1f3-e4002b70f620
Autor:
Scott, RA, Freitag, DF, Li, L, Chu, AY, Surendran, P, Young, R, Grarup, N, Stancáková, A, Chen, Y, Varga, TV, Yaghootkar, H, Luan, J, Zhao, JH, Willems, SM, Wessel, J, Wang, S, Maruthur, N, Michailidou, K, Pirie, A, Van Der Lee, SJ, Gillson, C, Al Olama, AA, Amouyel, P, Arriola, L, Arveiler, D, Aviles-Olmos, I, Balkau, B, Barricarte, A, Barroso, I, Garcia, SB, Bis, JC, Blankenberg, S, Boehnke, M, Boeing, H, Boerwinkle, E, Borecki, IB, Bork-Jensen, J, Bowden, S, Caldas, C, Caslake, M, Cupples, LA, Cruchaga, C, Czajkowski, J, Den Hoed, M, Dunn, JA, Earl, HM, Ehret, GB, Ferrannini, E, Ferrieres, J, Foltynie, T, Ford, I, Forouhi, NG, Gianfagna, F, Gonzalez, C, Grioni, S, Hiller, L, Jansson, JH, Jørgensen, ME, Jukema, JW, Kaaks, R, Kee, F, Kerrison, ND, Key, TJ, Kontto, J, Kote-Jarai, Z, Kraja, AT, Kuulasmaa, K, Kuusisto, J, Linneberg, A, Liu, C, Marenne, G, Mohlke, KL, Morris, AP, Muir, K, Müller-Nurasyid, M, Munroe, PB, Navarro, C
Publikováno v:
Scott, RA; Freitag, DF; Li, L; Chu, AY; Surendran, P; Young, R; et al.(2016). A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. Science Translational Medicine, 8(341). doi: 10.1126/scitranslmed.aad3744. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0zq8d76w
Copyright 2016 by the American Association for the Advancement of Science; all rights reserved. Regulatory authorities have indicated that new drugs to treat type 2 diabetes (T2D) should not be associated with an unacceptable increase in cardiovascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::4057613d42af65720842e4c5930ae8f7
http://www.escholarship.org/uc/item/0zq8d76w
http://www.escholarship.org/uc/item/0zq8d76w